Assignee

BIODESIX INC

US41 patents

Top patents by PatentIndex Score

US7736905B2Jun 15, 2010

Method and system for determining whether a drug will be effective on a patient with a disease

BIODESIX INC72 citations95

US9477906B2Oct 25, 2016

Classification generation method using combination of mini-classifiers with regularization and uses thereof

BIODESIX INC21 citations92

US7906342B2Mar 15, 2011

Monitoring treatment of cancer patients with drugs targeting EGFR pathway using mass spectrometry of patient samples

BIODESIX INC23 citations92

US7879620B2Feb 1, 2011

Method and system for determining whether a drug will be effective on a patient with a disease

BIODESIX INC24 citations92

US7867775B2Jan 11, 2011

Selection of head and neck cancer patients for treatment with drugs targeting EGFR pathway

BIODESIX INC21 citations92

US7858390B2Dec 28, 2010

Selection of colorectal cancer patients for treatment with drugs targeting EGFR pathway

BIODESIX INC26 citations92

US7858389B2Dec 28, 2010

Selection of non-small-cell lung cancer patients for treatment with monoclonal antibody drugs targeting EGFR pathway

BIODESIX INC30 citations92

US9279798B2Mar 8, 2016

Deep-MALDI TOF mass spectrometry of complex biological samples, e.g., serum, and uses thereof

BIODESIX INC18 citations89

US8718996B2May 6, 2014

Method for predicting whether a cancer patient will not benefit from platinum-based chemotherapy agents

BIODESIX INC19 citations84

US10489550B2Nov 26, 2019

Predictive test for aggressiveness or indolence of prostate cancer from mass spectrometry of blood-based sample

BIODESIX INC13 citations83

US9779204B2Oct 3, 2017

Predictive test for aggressiveness or indolence of prostate cancer from mass spectrometry of blood-based sample

BIODESIX INC7 citations83

US9563744B1Feb 7, 2017

Method of predicting development and severity of graft-versus-host disease

BIODESIX INC9 citations83

US8024282B2Sep 20, 2011

Method for reliable classification of samples in clinical diagnostics using an improved method of classification

BIODESIX INC11 citations83

US10217620B2Feb 26, 2019

Early detection of hepatocellular carcinoma in high risk populations using MALDI-TOF mass spectrometry

BIODESIX INC6 citations82

US10037874B2Jul 31, 2018

Early detection of hepatocellular carcinoma in high risk populations using MALDI-TOF mass spectrometry

BIODESIX INC6 citations82

US10007766B2Jun 26, 2018

Predictive test for melanoma patient benefit from antibody drug blocking ligand activation of the T-cell programmed cell death 1 (PD-1) checkpoint protein and classifier development methods

BIODESIX INC9 citations81

US9606101B2Mar 28, 2017

Deep MALDI TOF mass spectrometry of complex biological samples, e.g., serum, and uses thereof

BIODESIX INC7 citations81

US11594403B1Feb 28, 2023

Predictive test for prognosis of myelodysplastic syndrome patients using mass spectrometry of blood-based sample

BIODESIX INC4 citations73

US9254120B2Feb 9, 2016

Method for predicting breast cancer patient response to combination therapy

BIODESIX INC5 citations73

US9653272B2May 16, 2017

Mass-spectral method for selection, and de-selection, of cancer patients for treatment with immune response generating therapies

BIODESIX INC2 citations72

US9211314B2Dec 15, 2015

Treatment selection for lung cancer patients using mass spectrum of blood-based sample

BIODESIX INC6 citations72

US10802027B2Oct 13, 2020

Compositions, methods and kits for diagnosis of lung cancer

BIODESIX INC6 citations71

US10713590B2Jul 14, 2020

Bagged filtering method for selection and deselection of features for classification

BIODESIX INC5 citations71

US10338074B2Jul 2, 2019

Compositions, methods and kits for diagnosis of lung cancer

BIODESIX INC3 citations71

US11894147B2Feb 6, 2024

Method for predicting risk of unfavorable outcomes, e.g., in COVID-19 hospitalization, from clinical characteristics and basic laboratory findings

BIODESIX INC2 citations70

US11476003B2Oct 18, 2022

Method for predicting risk of unfavorable outcomes, e.g., in COVID-19 hospitalization, from clinical characteristics and basic laboratory findings

BIODESIX INC3 citations70

US10950348B2Mar 16, 2021

Predictive test for patient benefit from antibody drug blocking ligand activation of the T-cell programmed cell death 1 (PD-1) checkpoint protein and classifier development methods

BIODESIX INC2 citations70

US10422729B1Sep 24, 2019

Blood sample separation devices and methods

BIODESIX INC4 citations64

US11150238B2Oct 19, 2021

Method for identification of cancer patients with durable benefit from immunotherapy in overall poor prognosis subgroups

BIODESIX INC1 citations62

US10593529B2Mar 17, 2020

Mass-spectral method for selection, and de-selection, of cancer patients for treatment with immune response generating therapies

BIODESIX INC1 citations62

US11193935B2Dec 7, 2021

Compositions, methods and kits for diagnosis of lung cancer

BIODESIX INC0 citations61

US11710539B2Jul 25, 2023

Predictive test for melanoma patient benefit from interleukin-2 (IL2) therapy

BIODESIX INC1 citations60

US11621057B2Apr 4, 2023

Classifier generation methods and predictive test for ovarian cancer patient prognosis under platinum chemotherapy

BIODESIX INC1 citations60

US11467167B2Oct 11, 2022

SRM methods in Alzheimer's disease and neurological disease assays

BIODESIX INC1 citations59

US12247980B2Mar 11, 2025

Compositions, methods and kits for diagnosis of lung cancer

BIODESIX INC0 citations56

US12230398B2Feb 18, 2025

Predictive test for patient benefit from antibody drug blocking ligand activation of the T-cell programmed cell death 1 (PD-1) checkpoint protein and classifier development methods

BIODESIX INC0 citations56

US12094587B2Sep 17, 2024

Apparatus and method for identification of primary immune resistance in cancer patients

BIODESIX INC1 citations55

US11913957B2Feb 27, 2024

Compositions, methods and kits for diagnosis of lung cancer

BIODESIX INC1 citations55

US10534002B2Jan 14, 2020

Selected reaction monitoring assays

BIODESIX INC0 citations49

US10870891B2Dec 22, 2020

Diagnostic test system for specific, sensitive and reproducible detection of circulating nucleic acids in whole blood

BIODESIX INC1 citations47

US11542340B1Jan 3, 2023

Antibodies targeting pulmonary nodule specific biomarkers and uses thereof

BIODESIX INC0 citations45

BIODESIX INC

Top patents by PatentIndex Score

Method and system for determining whether a drug will be effective on a patient with a disease

Classification generation method using combination of mini-classifiers with regularization and uses thereof

Monitoring treatment of cancer patients with drugs targeting EGFR pathway using mass spectrometry of patient samples

Method and system for determining whether a drug will be effective on a patient with a disease

Selection of head and neck cancer patients for treatment with drugs targeting EGFR pathway

Selection of colorectal cancer patients for treatment with drugs targeting EGFR pathway

Selection of non-small-cell lung cancer patients for treatment with monoclonal antibody drugs targeting EGFR pathway

Deep-MALDI TOF mass spectrometry of complex biological samples, e.g., serum, and uses thereof

Method for predicting whether a cancer patient will not benefit from platinum-based chemotherapy agents

Predictive test for aggressiveness or indolence of prostate cancer from mass spectrometry of blood-based sample

Predictive test for aggressiveness or indolence of prostate cancer from mass spectrometry of blood-based sample

Method of predicting development and severity of graft-versus-host disease

Method for reliable classification of samples in clinical diagnostics using an improved method of classification

Early detection of hepatocellular carcinoma in high risk populations using MALDI-TOF mass spectrometry

Early detection of hepatocellular carcinoma in high risk populations using MALDI-TOF mass spectrometry

Predictive test for melanoma patient benefit from antibody drug blocking ligand activation of the T-cell programmed cell death 1 (PD-1) checkpoint protein and classifier development methods

Deep MALDI TOF mass spectrometry of complex biological samples, e.g., serum, and uses thereof

Predictive test for prognosis of myelodysplastic syndrome patients using mass spectrometry of blood-based sample

Method for predicting breast cancer patient response to combination therapy

Mass-spectral method for selection, and de-selection, of cancer patients for treatment with immune response generating therapies

Treatment selection for lung cancer patients using mass spectrum of blood-based sample

Compositions, methods and kits for diagnosis of lung cancer

Bagged filtering method for selection and deselection of features for classification

Compositions, methods and kits for diagnosis of lung cancer

Method for predicting risk of unfavorable outcomes, e.g., in COVID-19 hospitalization, from clinical characteristics and basic laboratory findings

Method for predicting risk of unfavorable outcomes, e.g., in COVID-19 hospitalization, from clinical characteristics and basic laboratory findings

Predictive test for patient benefit from antibody drug blocking ligand activation of the T-cell programmed cell death 1 (PD-1) checkpoint protein and classifier development methods

Blood sample separation devices and methods

Method for identification of cancer patients with durable benefit from immunotherapy in overall poor prognosis subgroups

Mass-spectral method for selection, and de-selection, of cancer patients for treatment with immune response generating therapies

Compositions, methods and kits for diagnosis of lung cancer

Predictive test for melanoma patient benefit from interleukin-2 (IL2) therapy

Classifier generation methods and predictive test for ovarian cancer patient prognosis under platinum chemotherapy

SRM methods in Alzheimer&#39;s disease and neurological disease assays

Compositions, methods and kits for diagnosis of lung cancer

Predictive test for patient benefit from antibody drug blocking ligand activation of the T-cell programmed cell death 1 (PD-1) checkpoint protein and classifier development methods

Apparatus and method for identification of primary immune resistance in cancer patients

Compositions, methods and kits for diagnosis of lung cancer

Selected reaction monitoring assays

Diagnostic test system for specific, sensitive and reproducible detection of circulating nucleic acids in whole blood

Antibodies targeting pulmonary nodule specific biomarkers and uses thereof

SRM methods in Alzheimer's disease and neurological disease assays